Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Momentum11on Feb 14, 2017 10:25am

65 Views

Post# 25842445

RE:RE:Question for Smartinvesting1

Right so the space can be 30,000 sq ft as long as the actual canopy is limited to the 10,000 sq ft the t2 producer is allowed. I believe that is what your saying? Lie was was a poor choice of words, but it is very misleading. Catherine, it is clear who you are, why not just come out with it and be a resource on this board for questions.

Bullboard Posts

What is the gold outlook for the rest of 2024?